|
Study of the Cost and Efficiency of HIV Prevention in Developing Countries |
Kenya; Uganda; Tanzania; South Africa; Belarus |
HIV/AIDS, Health Economics and Effectiveness |
|
|
|
Building Capacity in the Estimation of Unmet Need for HIV Care |
United States |
HIV/AIDS, Epidemiology and Surveillance |
|
|
|
Axios Program Evaluation Program |
South Africa; Nigeria; Pakistan; Malaysia; Thailand; Philippines; United Arab Emirates |
Health Economics and Effectiveness, Access or Barriers to Care |
|
|
|
Making Better Decisions: Policy Modeling for AIDS and Drug Abuse [II] |
United States |
HIV/AIDS, Health Economics and Effectiveness |
|
|
|
California Health Care Policy Research Program |
United States |
Health Economics and Effectiveness |
|
|
|
A Phase III Multicenter Randomized Study of the Biological and Clinical Efficacy of Subcutaneous Recombinant, Human Interleukin-2 in HIV-Infected Patients with Low CD4+ Counts (SILCAAT) |
United States |
HIV/AIDS, Pharmacology and Drug Treatment, Health Economics and Effectiveness |
|
|
|
High-Quality, High Volume Cataract Surgery at Aravind as a Model for Male Circumcision |
India |
HIV/AIDS, Surgery and Anesthesia, Risk Reduction and Prevention |
|
|
|
Congenital Syphilis Elimination Cost-Effectiveness Analysis |
Burundi; Comoros; Djibouti; Madagascar; Malawi; Mauritius; Mozambique; Rwanda; Tanzania; Zambia; Zimbabwe; Cameroon; Central African Republic; Chad; Congo (Brazzaville); Gabon; Sao Tome and Principe; Sudan; Tunisia; Botswana; Namibia; South Africa; Swaziland; Benin; Burkina Faso; Ivory Coast; Ghana; Guinea; Mali; Nigeria; Sierra Leone; Togo; Kazakhstan; Kyrgyzstan; Uzbekistan; China; Mongolia; Afghanistan; Bangladesh; India; Maldives; Nepal; Sri Lanka; Cambodia; Indonesia; Viet Nam; Laos; Malaysia; Myanmar; Thailand; Philippines; Jordan; Oman; Saudi Arabia; Belarus; Czech Republic; Estonia; Germany; Hungary; Lithuania; Macedonia; Moldova; Romania; United Kingdom; Costa Rica; El Salvador; Guatemala; Honduras; Mexico; Panama; Argentina; Bolivia; Brazil; Chile; Colombia; Ecuador; Guyana; Paraguay; Peru; Uruguay; Antigua and Barbuda; Cuba; Dominica; Dominican Republic; Grenada; Trinidad and Tobago; Fiji; Kiribati; Papua New Guinea |
Sexually Transmitted Infections (STIs), Health Economics and Effectiveness |
|
|
|
GHER-Global Health Effectiveness Review |
United States |
Health Economics and Effectiveness |
|
|
|
Making Better Decision: Policy Modeling for AIDS and Drug Abuse [I] |
United States |
HIV/AIDS, Health Economics and Effectiveness, Substance Abuse |
|
|
|
Global Health Comparative Effectiveness: A Data Synthesis Method Applied to HIV |
United States |
HIV/AIDS, Health Economics and Effectiveness |
|
|
|
Unit Cost Reference Database |
United States |
Health Economics and Effectiveness |
|
|
|
Making Better Decisions: Policy Modeling for AIDS and Drug Abuse |
United States |
HIV/AIDS, Health Economics and Effectiveness, Substance Abuse |
|
|
|
Unit Cost Reference Database |
United States |
Health Economics and Effectiveness |
|
|
|
Economic Analysis for Prevention of Disease (EMPoD) |
United States |
Health Economics and Effectiveness |
|
|
|
Making Better Decisions: Policy Modeling for AIDS and Drug Abuse |
United States |
HIV/AIDS, Tuberculosis, Health Economics and Effectiveness |
|
|
